PKU monitoring – phenylalanine and tyrosine

Description
Analysis of the amino acids phenylalanine (phe) and tyrosine (tyr) by liquid chromatography-tandem mass spectrometry.
Clinical details

For monitoring patients with known inherited metabolic disease affecting phenylalanine and tyrosine metabolism, including phenylketonuria (PKU) and tyrosinaemia.

Related condition
Reference range

As a guide, for patients with phenylketonuria on diet, the target ranges are:

0 – 12 years 120-360 µmol/L

>12 years 120-600 µmol/L

In pregnancy 120-300 µmol/L

Units

umol/L

Synonyms

PKU, Phenylalanine, Tyrosine, Metabolic, Phe, PKU Mon, Phenylketonuria

Testing site
Synnovis : Reference Services : Blackfriars Hub
Laboratory
Inherited Metabolic Disease
Sample type and volume required

Bloodspot card. Minimum two >7 mm diameter bloodspots.

Blood must be soaked through. Bloodspots should NOT be multi-spotted, compressed or creased.

Samples should be received into the laboratory within 14 days of collection

Special sample instructions

Guthrie cards are the same as used for the National Newborn Screening Programme. Please ensure bloodspot cards are clearly labelled requesting either PKU monitoring or Tyrosinaemia analysis as appropriate

Storage and transport

Send via first class post

Turnaround time

Same day if received by 10am (Mon-Fri)

Contacts

Inherited Metabolic Diseases Unit at Blackfriars Hub
IMD Duty Biochemist: 07592 502653
Email: ClinicalScientistIMD@synnovis.co.uk
Reference Chemistry
Floor 1, Synnovis hub
Friars Bridge Court
41-43 Blackfriars Road
London
SE1 8NZ

Last updated:

Back to search